  A sperm-driven micromotor is presented as cargo-delivery system for the
treatment of gynecological cancers. This particular hybrid micromotor is
appealing to treat diseases in the female reproductive tract, the physiological
environment that sperm cells are naturally adapted to swim in. Here, the single
sperm cell serves as an active drug carrier and as driving force, taking
advantage of its swimming capability, while a laser-printed microstructure
coated with a nanometric layer of iron is used to guide and release the sperm
in the desired area by an external magnet and structurally imposed mechanical
actuation, respectively. The printed tubular microstructure features four arms
which release the drug-loaded sperm cell in situ when they bend upon pushing
against a tumor spheroid, resulting in the drug delivery, which occurs when the
sperm squeezes through the cancer cells and fuses with cell membrane. Sperms
also offer higher drug encapsulation capability and carrying stability compared
to other nano and microcarriers, minimizing toxic effects and unwanted drug
accumulation. Moreover, sperms neither express pathogenic proteins nor
proliferate to form undesirable colonies, unlike other cells or microorganisms
do, making this bio-hybrid system a unique and biocompatible cargo delivery
platform for various biomedical applications, especially in gynecological
healthcare.
